Search

Your search keyword '"Pons-Estel, Guillermo J"' showing total 281 results

Search Constraints

Start Over You searched for: Author "Pons-Estel, Guillermo J" Remove constraint Author: "Pons-Estel, Guillermo J"
281 results on '"Pons-Estel, Guillermo J"'

Search Results

1. Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry)

2. Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

3. OMERACT systemic lupus erythematosus domain survey

4. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance

5. Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries

6. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

7. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry

8. Humoral and T Cell Response to SARS‐CoV‐2 Vaccination in Patients With Rheumatoid Arthritis

9. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry—protocol and preliminary data

10. Evaluating the Construct of Damage in Systemic Lupus Erythematosus

11. Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study

12. Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America

14. Contributors

15. Epidemiology

17. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

18. Humoral and T‐cell response to SARS‐CoV‐2 vaccination in patients with rheumatoid arthritis

20. LSO-086 Pregnancy outcomes in systemic lupus erythematosus: data from a multiethnic, multinational Latin American cohort

21. LP-149 Latin-American systemic lupus erythematosus clusters

22. LP-139 Baseline characteristics of a longitudinal, multinational, multiethnic study of lupus patients, with or without lupus nephritis

23. LSO-023 Clinical characteristics of SARS-CoV-2 infection in patients with systemic lupus erythematosus in Argentina: data from the SAR-COVID national registry

24. LP-061 Male sex and disease activity at diagnosis are predictors of severe hemolytic anemia in patients with systemic lupus erythematosus: data from a multiethnic Latin American cohort

26. The Rise and Rise of Lupus

27. Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohort

28. Seguridad de las drogas biológicas y sintéticas dirigidas utilizadas en pacientes con enfermedades reumáticas inmunomediadas. Datos del registro BIOBADASAR 3.0

29. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

31. Características clínicas y evolución de la infección por SARS-CoV-2 en pacientes con lupus eritematoso sistémico en Argentina: datos del registro nacional SAR-COVID

33. Evaluating the Construct of Damage in Systemic Lupus Erythematosus

34. Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry)

35. Supplemental Material - Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohort

36. Musculoskeletal Involvement

38. Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines

41. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL)

42. Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study

43. Controversies in Systemic Lupus Erythematosus 2021

45. Addressing health disparities as a function of ethnicity in systemic lupus erythematosus patients

46. List of Contributors

47. Epidemiology

49. Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America

Catalog

Books, media, physical & digital resources